Phenobarbital
| Phenobarbital | |
|---|---|
| Salts [] | |
|---|---|
| Sodium phenobarbital | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 232.23 g/mol [1] |
| Appearance | Crystals (3 different phases) [1] |
| Odor | Odorless [1] |
| Taste | Slightly bitter taste [1] |
| Melting point | 345 to 352 °F (NTP, 1992) [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1] |
| Solubility | less than 0.1 mg/mL at 57 °F (NTP, 1992) [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H12N2O3 |
| IUPAC name | 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione |
| SMILES | CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2 |
| InChI | InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17) |
| InChIKey | DDBREPKUVSBGFI-UHFFFAOYSA-N |
| CAS number | 50-06-6 |
| UNII | YQE403BP4D |
| PubChem CID | 4763 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Within 5 min (IV); 30 min (PO) |
| Elimination half-life | 53–118 hours |
| Duration of action | 4 hours–2 days |
| Metabolism | Liver (mostly CYP2C19) |
| Excretion | Kidney and fecal |
| Routes of administration | By mouth, rectal, parenteral, intramuscular, intravenous[3][4] |
| Dependence liability | High[5] |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - oral: 162 +/- - oral: 660 mg/kg /Sodium - ip: 151 mg/kg - sc: 200 mg/kg [1] |
Phenobarbital (also known as Phenobarbitone, Luminal, Phenobarbitol, Fenobarbital, Nunol, Phenylethylbarbiturate, Dormiral, Gardenal, Gardepanyl or Neurobarb) is a substance of the barbiturate class.
Chemistry
Salts []
Stereochemistry []
Phenobarbital is achiral.
Druglikeness
Lipinski's rule of five
Phenobarbital matches Lipinski's rule of five.Reagents
There are currently 2 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- antiepileptics (N03)
- antiepileptics (N03A)
- barbiturates and derivatives (N03AA)
- (N03AA02)
- phenobarbital (N03AA02)
MeSH Classification
- anticonvulsants (M0001382)
- hypnotics and sedatives (M0010885)
- excitatory amino acid antagonists (M0028006)
- gaba modulators (M0028093)
- cytochrome p-450 cyp2b6 inducers (M0590393)
- cytochrome p-450 cyp3a inducers (M0590399)
Mechanism of action []
Phenobarbital acts on GABAA receptors, increasing synaptic inhibition. This has the effect of elevating seizure threshold and reducing the spread of seizure activity from a seizure focus. Phenobarbital may also inhibit calcium channels, resulting in a decrease in excitatory transmitter release. The sedative-hypnotic effects of phenobarbital are likely the result of its effect on the polysynaptic midbrain reticular formation, which controls CNS arousal. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| CYP3A | induction | 177 (15 contraindicated) |
|---|---|---|
| CYP2C9 | induction | 81 (1 contraindicated) |
| GABRA1 | shared target | 64 |
| GABRA2 | shared target | 61 |
| GABRA3 | shared target | 61 |
| GABRA4 | shared target | 61 |
| GABRA5 | shared target | 61 |
| GABRA6 | shared target | 61 |
| GABRB1 | shared target | 61 |
| GABRB2 | shared target | 61 |
| GABRB3 | shared target | 61 |
| GABRD | shared target | 61 |
| GABRE | shared target | 61 |
| GABRG1 | shared target | 61 |
| GABRG2 | shared target | 61 |
| GABRG3 | shared target | 61 |
| GABRP | shared target | 61 |
| GABRQ | shared target | 61 |
| CYP2B6 | induction | 37 (1 contraindicated) |
Medical side effects []
80 side effects listed on drug labels in SIDER 4.1 (phenobarbital).
- Congenital anomaly
- Developmental delay
- Anaemia megaloblastic
- Angioedema
- Apnoea
- Asthma
- Ataxia
- Blister
- Dermatitis bullous
- Coma
- Confusional state
- Feeling abnormal
- Constipation
- Delirium
- Dermatitis
- Rash
- Dermatitis exfoliative
- Dizziness
- Syncope
- Somnolence
- Localised oedema
- Emotional disorder
- Toxic epidermal necrolysis
- Extravasation
- Body temperature increased
- Folate deficiency
- Hallucination
- Headache
- Hepatitis
- Hypersensitivity
- Hypocalcaemia
- Hypotension
- Body temperature decreased
- Hypothermia
- Irritability
- Laryngospasm
- Lethargy
- Nausea
- Necrosis
- Nervousness
- Tension
- Nightmare
- Nystagmus
- Osteomalacia
- Pain
- Renal failure
- Shock
- Erythema multiforme
- Stevens-Johnson syndrome
- Loss of consciousness
- Erythema
- Urticaria
- Vertigo
- Vitamin K deficiency
- Vomiting
- Agitation
- Excitement
- Hyperkinesia
- Mood swings
- Affect lability
- Depressed level of consciousness
- Injection site reaction
- Hepatocellular injury
- Liver injury
- Hangover
- Myalgia
- Musculoskeletal discomfort
- Thinking abnormal
- Mental disability
- Respiratory depression
- Pulmonary function test decreased
- Anxiety
- Phobia
- Suicidal ideation
- Bradycardia
- Arthralgia
- Suicidal behaviour
- Hypoxia
- Respiratory failure
- Hypoventilation
Indications
- Anxiety
- Cardiac failure
- Cerebral haemorrhage
- Cholera
- Chorea
- Convulsion
- Eclampsia
- Epilepsy
- Essential hypertension
- Excitability
- Febrile convulsion
- Haemorrhage
- Hyperthyroidism
- Insomnia
- Labyrinthitis
- Meningitis
- Motion sickness
- Nausea
- Partial seizures
- Pylorospasm
- Status epilepticus
- Tension
- Tetanus
- Vomiting
Subjective effects []
| bonzi / Phenobarbital [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 14 experience reports involving phenobarbital on Erowid: []- "Polypharmacy, Sleep, and Addiction" by Az
- "Calming Effect" by WhiteRook
- "Sedate and Contented" by ClapOnCannabis
- "Barbies with Baggage" by SomeonElse
- "Just Relax" by Cayana
- "My Bad Idea" by Dick
- "No Big Deal" by Poppy
- "4 Days of Nothing" by Anotherlogan
- "A Physical Drunk Feeling" by DaCypher
- "Of Little Recreational Value" by Jdub
- "Dog Pills" by Pnau
- "I'm Still Waiting" by Alex
- "Cheap Enough" by Tool_Head
- "Hooked on Them Since Age 19" by ASB
- "My full drug career to this point. (Feel free to skim )" by Solid-Ambition-6635 (28 upvotes)
- "Tripping third day in a row from 225mg DXM + 660mg phenobarbital" by dxvt88 (1 upvotes)
- "1500mg phenobarbital diluted in 90ml 96% ethanol/68kg throughout 2 days" by dxvt88 (1 upvotes)
- "A Lackluster Venture In to Barb-Land" by Lysergedelia (1 upvotes)
Legal status []
- Australia: Phenobarbital is a Schedule 4.
- Brazil: Phenobarbital is a B1.[6]
- Canada: Phenobarbital is a Schedule IV.
- Germany: Phenobarbital is Prescription only/Anlage III.
- United Kingdom: Phenobarbital is a Class B under the "Misuse of Drugs Act 1971".
- United States: Phenobarbital is a Schedule IV under the "Controlled Substances Act".[7]
- European Union: Phenobarbital is Prescription only.
- Other: Phenobarbital is a SE: Förteckning IV, In general: ℞ (Prescription only).[8]
See also []
External links []
- Phenobarbital (Wikipedia)
- Phenobarbital (PubChem)
- Phenobarbital (Wikidata)
- Phenobarbital (DrugBank)
- Phenobarbital (ChEMBL)
- Phenobarbital (ChEBI)
- Phenobarbital (Common Chemistry)
- Phenobarbital (HMDB)
- Phenobarbital (KEGG)
- Phenobarbital (EPA DSSTox)
- Phenobarbital (Effect Index)
- Phenobarbital (UNII)
- Phenobarbital (SIDER)
- Phenobarbital (Erowid)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4763, Phenobarbital. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4763
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Phenobarbital. UNII: YQE403BP4D. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/YQE403BP4D
Hocker S, Clark S, Britton J. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience. Epilepsia. October 2018; 59 Suppl 2():193–197. PMID 30159873. https://doi.org/10.1111/epi.14488
Barbiturate (Oral Route, Parenteral Route, Rectal Route) Proper Use. Mayo Clinic. 7 August 2024. https://www.mayoclinic.org/drugs-supplements/barbiturate-oral-route-parenteral-route-rectal-route/proper-use/drg-20069290
Bassert JM. McCurnin's Clinical Textbook for Veterinary Technicians - E-Book. Elsevier Health Sciences. 2017. https://books.google.com/books?id=9ARODgAAQBAJ&pg=PA955
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Sezaby- phenobarbital sodium injection. DailyMed. 6 January 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c7d0402-4977-4c25-bc4b-11db91339e9a
Fenobarbital. Läkemedelsverket. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4pobsu8zs2vert1/fenobarbital
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:01:39 |
| drugspro | ok | 2026-11-20 18:01:35 |
| erowid | ok | 2026-11-20 18:01:42 |
| gsrs | ok | 2026-11-20 18:01:36 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015305) | 2026-11-20 18:01:35 |
| kegg | ok | 2026-11-20 18:01:39 |
| pubchem | ok | 2026-11-20 18:01:35 |
| ok | 2026-11-20 18:01:35 | |
| sider | ok | 2026-11-20 18:01:35 |
| structure | ok | 2026-11-20 18:01:35 |
| wikipedia | ok | 2026-11-20 18:01:35 |